You just read:

Following Congressional Hearing Investigating Mylan and Epi-Pen, Imprimis Pharmaceuticals Founder and CEO Publishes Drug Pricing Monograph

News provided by

Imprimis Pharmaceuticals, Inc.

22 Sep, 2016, 08:30 ET